CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,616,368
+$401,401 QoQ
Shares Held
980,321
+23.9% QoQ
Ownership
0.928%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. SRPT ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,616,368 | 980,321 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,214,967 | 791,129 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,471,042 | 765,383 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,738,339 | 609,151 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,523,296 | 673,877 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $41,246,291 | 646,291 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $75,841,640 | 623,749 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $76,401,332 | 611,749 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $95,551,606 | 604,757 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $76,308,772 | 589,439 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $55,583,409 | 576,412 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $67,925,748 | 560,351 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $63,448,889 | 554,042 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $71,666,638 | 519,964 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $66,922,757 | 516,459 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $54,677,505 | 494,640 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,554,543 | 487,654 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $37,441,744 | 479,285 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,168,523 | 468,279 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $38,717,584 | 418,659 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $31,390,867 | 403,793 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $29,397,016 | 394,432 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $66,567,650 | 390,449 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $53,993,509 | 384,487 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $57,751,100 | 360,179 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $33,063,257 | 338,001 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||